| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 58.6751 | 63 |
| GSM780708 | Untreated after 4 days (C2_1) | 54.3309 | 58 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.2151 | 58 |
| GSM780719 | Untreated after 4 days (C1_2) | 64.8256 | 67 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.1906 | 58 |
| GSM780721 | Untreated after 4 days (C3_2) | 61.6416 | 65 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.1029 | 63 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 58.257 | 63 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 58.6232 | 63 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 54.2477 | 58 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 62.655 | 66 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 67.0528 | 68 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 67.0528 | 68 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 65.1175 | 67 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 92.7875 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 73.1246 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.7276 | 59 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 85.0935 | 73 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.6547 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 58.7201 | 63 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 56.0466 | 61 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.4162 | 55 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.6162 | 57 |